FEIM vs. CTKB, LAB, SENS, EYPT, ALNT, AEHR, QSI, QTRX, MASS, and SEER
Should you be buying Frequency Electronics stock or one of its competitors? The main competitors of Frequency Electronics include Cytek Biosciences (CTKB), Standard BioTools (LAB), Senseonics (SENS), EyePoint Pharmaceuticals (EYPT), Allient (ALNT), Aehr Test Systems (AEHR), Quantum-Si (QSI), Quanterix (QTRX), 908 Devices (MASS), and Seer (SEER). These companies are all part of the "measuring and control equipment" industry.
Frequency Electronics vs.
Cytek Biosciences (NASDAQ:CTKB) and Frequency Electronics (NASDAQ:FEIM) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, community ranking, earnings, institutional ownership, media sentiment and dividends.
Cytek Biosciences has a beta of 1.41, suggesting that its share price is 41% more volatile than the S&P 500. Comparatively, Frequency Electronics has a beta of 0.43, suggesting that its share price is 57% less volatile than the S&P 500.
In the previous week, Cytek Biosciences had 1 more articles in the media than Frequency Electronics. MarketBeat recorded 3 mentions for Cytek Biosciences and 2 mentions for Frequency Electronics. Cytek Biosciences' average media sentiment score of 0.86 beat Frequency Electronics' score of 0.47 indicating that Cytek Biosciences is being referred to more favorably in the media.
Frequency Electronics has a net margin of 13.02% compared to Cytek Biosciences' net margin of -5.05%. Frequency Electronics' return on equity of 21.49% beat Cytek Biosciences' return on equity.
Frequency Electronics has lower revenue, but higher earnings than Cytek Biosciences. Cytek Biosciences is trading at a lower price-to-earnings ratio than Frequency Electronics, indicating that it is currently the more affordable of the two stocks.
Cytek Biosciences presently has a consensus price target of $6.42, suggesting a potential upside of 69.98%. Given Cytek Biosciences' stronger consensus rating and higher probable upside, analysts plainly believe Cytek Biosciences is more favorable than Frequency Electronics.
69.5% of Cytek Biosciences shares are held by institutional investors. Comparatively, 58.6% of Frequency Electronics shares are held by institutional investors. 9.6% of Cytek Biosciences shares are held by insiders. Comparatively, 26.1% of Frequency Electronics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Frequency Electronics received 66 more outperform votes than Cytek Biosciences when rated by MarketBeat users. Likewise, 60.69% of users gave Frequency Electronics an outperform vote while only 45.83% of users gave Cytek Biosciences an outperform vote.
Summary
Frequency Electronics beats Cytek Biosciences on 10 of the 18 factors compared between the two stocks.
Get Frequency Electronics News Delivered to You Automatically
Sign up to receive the latest news and ratings for FEIM and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Frequency Electronics Competitors List
Related Companies and Tools
This page (NASDAQ:FEIM) was last updated on 4/24/2025 by MarketBeat.com Staff